3rd Conference on Therapeutic Resistance in Cancer

Venue: Hyatt Regency Hotel

Location: Montreal, Quebec, Canada

Event Date/Time: Mar 15, 2012 End Date/Time: Mar 17, 2012
Registration Date: Mar 08, 2012
Early Registration Date: Feb 23, 2012
Report as Spam


Clinicians and scientists working in translational cancer research are invited to explore the importance of therapeutic resistance in the pursuit of personalized medicine. The focus will be on clinical relevance and biomarker discovery.

Session 1: Intrinsic vs acquired resistance
Session 2: Tumor heterogeneity
Session 3: Host-tumor interactions
Session 4: Biomarker-driven and biopsy-driven trials
Session 5: Challenges of 'omics data
Session 6: Personalized medicine in action
Session 7: New technologies and methodologies

Discussions will focus on the challenges of
therapeutic resistance in personalized medicine, on technical and logistical issues pertaining to personalized medicine, and on creating opportunities for collaborations.

Please visit www.resistanceincancer2012.com for more details on the conference.

Speakers from UCLA Jonsson Comprehensive Cancer Center, University of Colorado, The Translational Genomics Research Institute (TGen), MD Anderson Cancer Center, McGill University, Abramson Cancer Center, Swiss Institute of Bioinformatics, University of California Santa Cruz (UCLA), Ontario Cancer Institute, University of Helsinki, H. Lee Moffitt Cnacer Center, George Mason University's Center for Applied Proteomics and Molecular Medicine.

The deadline for abstracts is February 10, 2012.


1255 Jeanne-Mance

Additional Information

Registration will close at a maximum of 250 attendees. Enquiries: services@safranevenements.ca Registration fees (before Feb 23, 2012): Students / Postdoctoral fellows (75$) Scientists / Clinicians (250$) Industry participants (500$)